SGLT2 inhibitor outcome trials: Future opportunities
Dr David Fitchett
Video navigation menu
- Glycemic control: unmet needs 00:01
- SGLT2 inhibitors 01:11
- The EMPA-REG OUTCOME trial 03:20
- Conclusions 07:58
This has no CME
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.